China Reform Health Management and Services Group Co Ltd
Launch date
Employees
Market cap
AUD1.5b
Enterprise valuation
AUD1.2b (Public information from Sep 2024)
Share price
CNY7.65 000503.SZ
Beijing China (HQ)
Financials
Estimates*
| CNY | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 130m | 207m | 253m | 311m | 330m |
| % growth | - | - | - | 60 % | 22 % | 23 % | 6 % |
| EBITDA | - | - | 73.6m | (111m) | (112m) | (65.7m) | (55.7m) |
| % EBITDA margin | - | - | 57 % | (53 %) | (44 %) | (21 %) | (17 %) |
| Profit | - | - | 17.4m | (243m) | (176m) | (84.5m) | (79.8m) |
| % profit margin | - | - | 13 % | (117 %) | (70 %) | (27 %) | (24 %) |
| EV / revenue | - | - | 112.1x | 31.9x | 57.9x | 27.9x | 35.7x |
| EV / EBITDA | - | - | 197.9x | -59.7x | -130.6x | -132.1x | -211.8x |
| R&D budget | - | - | 5.8m | 16.4m | 16.3m | 9.6m | <1m |
| R&D % of revenue | - | - | 4 % | 8 % | 6 % | 3 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
